跳至主要内容
临床试验/DRKS00024734
DRKS00024734已完成不适用

Retrospective evaluation of image-guided, interventional treatments of venous and arteriovenous malformations in the hand - AVM_VM_Hand

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 60 人开始时间: 2023年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

Conclusion This study reveals that sclerotherapy using gelified ethanol and/or polidocanol foam is both effective and safe for treating VMs of the hand. Repetitive procedures may be needed to achieve appropriate relief of symptoms and improved function. Previously surgically or minimally invasively treated patients similarly benefit from sclerotherapy while showing comparably low complication rates to therapy-naive patients.

研究设计

研究类型
Observational

入排标准

年龄范围
5 Years 至 one(—)
性别
All

入选标准

  • Patients diagnosed with arteriovenous or venous malformation of the hand and having undergone image-guided treatment by sclerotherapy or embolization in the form of one or more sessions during the period 01/01/2017 to 12/30/2020.
  • - Patients who have received the above procedures with the following sclerotherapy/embolization agents: Polidocanol, gelled alcohol, EVOH-based liquid embolization agents (EVOH = ethylene vinyl alcohol copolymer).

排除标准

  • - Patients with arteriovenous or venous malformation without involvement of the hand (wrist, metacarpal, finger).
  • - Patients who have received the above procedures with sclerosing/embolizing agents elsewhere, e.g., bleomycin
  • - Patients who have received otherwise image-guided interventional procedures, e.g., electrosclerotherapy

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验